• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PMEPA1 在泛癌中的诊断和治疗价值及其与肿瘤免疫的相关性。

Diagnostic and therapeutic values of PMEPA1 and its correlation with tumor immunity in pan-cancer.

机构信息

Department of Orthopaedics, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai 519000, Guangdong, China.

Department of Ophthalmology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, Guangdong, China.

出版信息

Life Sci. 2021 Jul 15;277:119452. doi: 10.1016/j.lfs.2021.119452. Epub 2021 Apr 5.

DOI:10.1016/j.lfs.2021.119452
PMID:33831430
Abstract

AIMS

The prostate transmembrane protein, androgen induced 1 (PMEPA1) is differentially expressed in pan-cancer. However, PMEPA1 specific role in cancers has not been fully clarified. This study aims to explore the potential role of Pmepa1 in pan-cancer and specific cancer, with a view to deepening the research on the pathological mechanism of cancer.

MAIN METHODS

The Perl language and R language were used to identify the correlation between PMEPA1 expression level and clinical indicators, prognosis values, tumor microenvironment, immune cells' infiltration, immune checkpoint genes, TMB and MSI. The Therapeutic Target Database was used for identifying potential therapeutic drugs that target the pathways that are significantly affected by PMEPA1 expression.

KEY FINDINGS

PMEPA1 differential expression significantly correlated with patients' age, race, tumors' stage and status. PMEPA1 high expression was closely correlated with poor prognosis in many cancer types, excluding prostate adenocarcinoma. PMEPA1 expression was closely related to tumor cells and the immune microenvironment in stromal and immune cells' level, immune cells' infiltration, immune checkpoint genes, tumor mutational burden and microsatellite instability. We also found that the activity of the olfactory transduction pathway was closely related to PMEPA1 expression. In pan-cancer, Trifluoperazine and Halofantrine have the potential to reduce PMEPA1 expression.

SIGNIFICANCE

This study integrated existing data to explore PMEPA1 potential function in cancers, provided insights for the future cancer-related studies.

摘要

目的

前列腺跨膜蛋白雄激素诱导 1(PMEPA1)在多种癌症中表达差异。然而,PMEPA1 在癌症中的具体作用尚未完全阐明。本研究旨在探讨 Pmepa1 在多种癌症和特定癌症中的潜在作用,以期深化对癌症病理机制的研究。

主要方法

使用 Perl 语言和 R 语言来识别 PMEPA1 表达水平与临床指标、预后值、肿瘤微环境、免疫细胞浸润、免疫检查点基因、TMB 和 MSI 的相关性。使用治疗靶点数据库来鉴定可能针对受 PMEPA1 表达显著影响的途径的治疗药物。

主要发现

PMEPA1 的差异表达与患者的年龄、种族、肿瘤分期和状态显著相关。在许多癌症类型中,PMEPA1 高表达与预后不良密切相关,但前列腺腺癌除外。PMEPA1 的表达与肿瘤细胞和基质及免疫细胞水平的免疫微环境、免疫细胞浸润、免疫检查点基因、肿瘤突变负荷和微卫星不稳定性密切相关。我们还发现嗅觉转导途径的活性与 PMEPA1 的表达密切相关。在泛癌症中,三氟拉嗪和卤泛群有可能降低 PMEPA1 的表达。

意义

本研究综合了现有数据,探讨了 PMEPA1 在癌症中的潜在功能,为未来的癌症相关研究提供了思路。

相似文献

1
Diagnostic and therapeutic values of PMEPA1 and its correlation with tumor immunity in pan-cancer.PMEPA1 在泛癌中的诊断和治疗价值及其与肿瘤免疫的相关性。
Life Sci. 2021 Jul 15;277:119452. doi: 10.1016/j.lfs.2021.119452. Epub 2021 Apr 5.
2
Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer.是膀胱癌中与细胞恶性程度和肿瘤微环境相关的预后生物标志物。
Front Immunol. 2021 Oct 28;12:705086. doi: 10.3389/fimmu.2021.705086. eCollection 2021.
3
Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer.基因异构体:前列腺癌的潜在生物标志物和治疗靶点。
Biomolecules. 2020 Aug 22;10(9):1221. doi: 10.3390/biom10091221.
4
PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.PMEPA1是一种雄激素调节的与NEDD4结合的蛋白质,具有细胞生长抑制功能,且在前列腺癌进展过程中表达降低。
Cancer Res. 2003 Aug 1;63(15):4299-304.
5
PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer.PMEPA1 可作为宫颈癌的预后生物标志物,并与免疫浸润相关。
J Immunol Res. 2022 Apr 20;2022:4510462. doi: 10.1155/2022/4510462. eCollection 2022.
6
Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer.PMEPA1基因的甲基化,前列腺癌中雄激素受体的负调节因子
Epigenetics. 2014 Jun;9(6):918-27. doi: 10.4161/epi.28710. Epub 2014 Apr 2.
7
Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN.PMEPA1基因沉默通过雄激素受体(AR)、NEDD4和磷酸酶及张力蛋白同源物(PTEN)促进前列腺癌细胞生长。
Oncotarget. 2015 Jun 20;6(17):15137-49. doi: 10.18632/oncotarget.3526.
8
Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer.前列腺癌高肿瘤突变负荷组与低肿瘤突变负荷组之间的基因表达谱和免疫微环境探索。
Int Immunopharmacol. 2020 Sep;86:106709. doi: 10.1016/j.intimp.2020.106709. Epub 2020 Jun 24.
9
Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.泛癌症分析 N4-乙酰胞苷接头蛋白 THUMPD1 作为预后和免疫治疗的预测因子。
Biosci Rep. 2021 Dec 22;41(12). doi: 10.1042/BSR20212300.
10
A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate.一个位于20号染色体q13区域的新型雄激素调节基因PMEPA1在前列腺中呈现高水平表达。
Genomics. 2000 Jun 15;66(3):257-63. doi: 10.1006/geno.2000.6214.

引用本文的文献

1
Identifying Immunomodulatory Subpopulations of Adipose Stromal Vascular Fraction and Stem/Stromal Cells Through Single-Cell Transcriptomics and Bulk Proteomics.通过单细胞转录组学和蛋白质组学鉴定脂肪基质血管成分和干/基质细胞的免疫调节亚群
Stem Cell Rev Rep. 2025 May 14. doi: 10.1007/s12015-025-10889-6.
2
Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC.PMEPA1在肝癌中的致癌作用及其与免疫耗竭和TGF-β激活的关系。
JHEP Rep. 2024 Sep 7;6(11):101212. doi: 10.1016/j.jhepr.2024.101212. eCollection 2024 Nov.
3
Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data.
基于单细胞和 bulk RNA-seq 数据综合分析的新辅助免疫治疗 NSCLC 患者预后模型的 B 细胞标记基因。
Clin Transl Oncol. 2024 Aug;26(8):2025-2036. doi: 10.1007/s12094-024-03428-1. Epub 2024 Apr 2.
4
Development and verification of a newly established cuproptosis-associated lncRNA model for predicting overall survival in uterine corpus endometrial carcinoma.一种新建立的用于预测子宫体子宫内膜癌总生存期的铜死亡相关长链非编码RNA模型的开发与验证
Transl Cancer Res. 2023 Aug 31;12(8):1963-1979. doi: 10.21037/tcr-23-61. Epub 2023 Aug 28.
5
Prognostic Values of METTL3 and Its Roles in Tumor Immune Microenvironment in Pan-Cancer.METTL3在泛癌中的预后价值及其在肿瘤免疫微环境中的作用
J Clin Med. 2022 Dec 25;12(1):155. doi: 10.3390/jcm12010155.
6
Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma.鉴定与 TGF-β 信号相关的基因特征,用于预测肺腺癌的免疫治疗和靶向治疗。
World J Surg Oncol. 2022 Jun 6;20(1):183. doi: 10.1186/s12957-022-02595-1.
7
PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer.PMEPA1 可作为宫颈癌的预后生物标志物,并与免疫浸润相关。
J Immunol Res. 2022 Apr 20;2022:4510462. doi: 10.1155/2022/4510462. eCollection 2022.
8
Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma.KIF15的综合泛癌分析揭示了其在鼻咽癌中的诊断和预后价值。
Front Oncol. 2022 Mar 11;12:772816. doi: 10.3389/fonc.2022.772816. eCollection 2022.
9
Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma.Ras 相关 GTP 结合蛋白 B(RRAGB)表达升高预示着结直肠腺癌患者总体生存不良,并构建了一个预后列线图。
Bioengineered. 2021 Dec;12(1):4620-4632. doi: 10.1080/21655979.2021.1956402.